Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-10-23
2007-10-23
Yaen, Christopher H. (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S091100, C435S325000
Reexamination Certificate
active
09825584
ABSTRACT:
Antibodies are disclosed which bind to ErbB3 protein and further possess any one or more of the following properties: an ability to reduce heregulin-induced formation of an ErbB2-ErbB3 protein complex in a cell which expresses ErbB2 and ErbB3; the ability to increase the binding affinity of heregulin for ErbB3 protein; and the characteristic of reducing heregulin-induced ErbB2 activation in a cell which expresses ErbB2 and ErbB3.
REFERENCES:
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4975278 (1990-12-01), Senter et al.
patent: 5183884 (1993-02-01), Kraus et al.
patent: 5258498 (1993-11-01), Huston et al.
patent: 5480968 (1996-01-01), Kraus et al.
patent: 5618920 (1997-04-01), Robinson et al.
patent: 5783186 (1998-07-01), Arakawa et al.
patent: 5783404 (1998-07-01), Koski
patent: 5820859 (1998-10-01), Kraus et al.
patent: 5916755 (1999-06-01), Kraus et al.
patent: 5968511 (1999-10-01), Akita et al.
patent: 444961 (1991-09-01), None
patent: 502812 (1992-09-01), None
patent: 0599274 (1994-06-01), None
patent: WO91/08214 (1991-06-01), None
patent: WO92/20798 (1992-11-01), None
patent: WO93/16185 (1993-08-01), None
patent: WO93/21319 (1993-10-01), None
patent: WO94/04679 (1994-03-01), None
patent: WO94/08007 (1994-04-01), None
patent: WO94/22478 (1994-10-01), None
patent: WO95/14776 (1995-06-01), None
patent: WO97/20858 (1997-06-01), None
Orlandi et al (Proc. Natl. Acad. Sci. USA, 86:3833-3837, 1989).
Ward et al (Nature 341:544-546, 1989).
Queen et al (PNAS 1989;86:10029-33).
Greenspan et al. (Nature Biotechnology 7: 936-937, 1999).
Kraus et al., “Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors”Proc. Natl. Acad. Sci. USA86:9193-9197 (Dec. 1989).
Lee et al., “Assignment of heregulin (HGL) to human chromosome 8p22-p11 by PCR analysis of somatic cell hybrid DNA”Genomics16:790-791 (1993).
Lemoine et al., “Expression of the ERBB3 gene product in breast cancer”Br. J. Cancer66:1116-1121 (1992).
Lemoine et al., “The erbB-3 gene in human pancreatic cancer”J. Pathol. 168:269-273 (1992).
Levi et al., “The Influence of Heregulins on Human Schwann Cell Proliferation”J. Neuroscience15(2):1329-1340 (Feb. 1995).
Lewis et al., “Growth Regulation of Human Breast and Ovarian Tumor Cells by Heregulin: Evidence for the Requirement of ErbB2 as a Critical Component in Mediating Heregulin Responsiveness”Cancer Research56:1457-1465 (Mar. 15, 1986).
Marchionni et al., “Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system”Nature362:312-318 (1993).
Morrissey et al., “Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2”Proc. Natl. Acad. Sci. USA92:1431-1435 (Feb. 1995).
Orr-Urtreger et al., “Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21”Proc. Natl. Acad. Sci. USA90:1867-1871 (1993).
Peles et al., “Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 Kd Glycoprotein That Induces Differentiation of Mammary Tumor Cells”Cell69(1) :205-216 (1992).
Plowman et al., “Heregulin induces tyrosine phosphorylation of HER4/p180erbB4”Nature(Letters to Nature) 366:473-475 (Dec. 2, 1993).
Plowman et al., “Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family”Proc. Natl. Acad. Sci. USA90:1746-1750 (Mar. 1993).
Plowman et al., “Molecular cloning and expression of an additional epidermal growth factor receptor-related gene”Proc. Natl. Acad. Sci. 87:4905-4909 (1990).
Poller et al., “Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas”J. Pathol. 168(3):275-280 (1992).
Rajkumar et al., “A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines”Br. J. Cancer70(3):459-465 (1994).
Rajkumar et al., “Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1”J. Pathol. (Published erratum appears in J.Pathol.1993 Oct.;171(2):154) 170:271-278 (1993).
Ram et al., “Mitogenic Activity of Neu Differentiation Factor/Heregulin Mimics That of Epidermal Growth Factor and Insulin-Like Growth Factor-1 in Human Mammary Epithelial Cells”J. Cellular Physiology163:589-596 (1995).
Sanidas et al., “Expression of the c-erbB-3 gene product in gastric cancer”Int. J. Cancer54:935-940 (1993).
Slamon et al., “Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2
eu Oncogene”Science235:177-182 (Jan. 9, 1987).
Slamon et al., “Studies of the HER-2
eu Proto-oncogene in Human Breast and Ovarian Cancer”Science244:707-712 (May 12, 1989).
Bacus et al., “Expression of the erbB-2 Family of Growth Factor Receptors and Their Ligands in Breast Cancers”Pathology Patterns(Suppl. 1) 102(4) :S13-S24 (1994).
Falls et al., “ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family”Cell72:801-815 (1993).
Fendly et al., “Characterization of Murine Monoclonal Antibodies Reactive to Either the Human Epidermal Growth Factor Receptor or HER2
eu Gene Product”Cancer Research50:1550-1558 (Mar. 1, 1990).
Friess et al., “Enhanced erbB-3 Expression in Human Pancreatic Cancer Correlates with Tumor Progression”Clinical Cancer Research1:1413-1420 (1995).
Griffiths et al., “Human Anti-Self Antibodies With High Specific From Phage Display Libraries”EMBO Journal12(2):725-734 (1993).
Guy et al., “Insect Cell-expressed p180erbB3Possesses an Impaired Tyrosine Kinase Activity”Proc. Natl. Acad. Sci. USA91:8132-8136 (Aug. 1994).
Holmes et al., “Identification of Heregulin, a Specific Activator of p185erbB2”Science256:1205-1210 (May 22, 1992).
Kim et al., “Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product”Journal of Biological Chemistry269(40):24747-24755 (1994).
Kraus et al., “Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells”Proc. Natl. Acad. Sci. 90:2900-2904 (1993).
Sliwkowski et al., “Coexpression of erbB2 and erbB3 Proteins Reconstitutes a High Affinity Receptor for Heregulin”Journal of Biological Chemistry269(20):14661-14665 (May 20, 1994).
Wallasch et al., “Heregulin-dependent regulation of HER2
eu oncogenic signaling by heterodimerization with HER3”EMBO Journal14(17):4267-4275 (1995).
Wen et al., “Neu differentiation factor: a transmembrane glycoprotein containing an EGF Domain and an Immunoglobulin Homology Unit”Cell69(3):559-572 (1992).
Wen et al., “Structural and functional aspects of the multiplicity of neu differentiation factors”Molecular&Cellular Biology14(3):1909-1919 (1994).
Akita Robert
Sliwkowski Mark
Conley Deirdre L.
Heller Ehrman LLP
Yaen Christopher H.
LandOfFree
Isolated nucleic acids, vectors and host cells encoding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nucleic acids, vectors and host cells encoding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nucleic acids, vectors and host cells encoding... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3903467